Lord’s Mark Industries Secures 200+ US FDA Registrations and Plans Export Launch
Lord’s Mark Industries Limited announced that it has become the first company in Asia to secure United States Food and Drug Administration (US FDA) registration for more than 200 surgical, medical‑care and hygiene products. The registration covers a broad portfolio that includes orthopaedic supports such as Lords Activeguard cervical‑thoracic braces, soft cervical collars, lumbar supports, abdominal belts, rib belts, chest binders, clavicle braces, shoulder immobilisers, arm slings, wrist and forearm splints, finger splints, thumb spica splints, elbow supports, tennis elbow braces, knee caps, knee immobilisers, hinged knee braces, patellar supports, ankle braces, ankle binders, foot‑drop splints and bunion correctors. Additional product lines comprise compression stockings, varicose‑vein stockings, hernia belts, scrotal supports, pregnancy supports, pelvic binders, cervical traction kits, traction belts, walking sticks, walkers, wheelchairs, orthopaedic cushions, heel cups, silicone insoles and posture correctors. The hygiene and medical‑care segment includes Lord’s Joywipes disinfectant and cleansing wipes, Lords Magic Elastic Adhesive Bandages, IV Cannula Fixator Elastic Adhesive Bandages, Lords Wonder Cotton Crepe Bandages, Lords Confidence adult diapers and Safelite sanitary napkins, as well as medical tourniquets and disposable hot and cold gel packs.
The company stated that it will begin exporting these FDA‑registered products to the United States in December 2026. This export initiative follows the early completion of a manufacturing capacity expansion at the company’s Silvassa facility, which was finished ahead of schedule. The expanded capacity is intended to meet the anticipated demand from international markets and to support the formation of partnerships with overseas distributors, healthcare suppliers and institutional buyers.
Lord’s Mark Industries also indicated that while the United States will be the primary export destination, it is exploring potential market entry in South America. Entry into any new market will be contingent upon compliance with product‑specific registration, import and distribution regulations applicable in each country.
Market context provided by Mordor Intelligence projects that the United States general surgical devices market will increase from US$6.69 billion in 2025 to US$9.67 billion by 2031, representing a compound annual growth rate (CAGR) of 6.35%. The South American counterpart is expected to grow from US$1.37 billion in 2025 to US$2.19 billion by 2031, at a CAGR of 8.20%.
Commenting on the achievement, Dr. Sachidanand Upadhyay, Founder, Managing Director and CEO of Lord’s Mark Industries Limited, said the certifications demonstrate the strength of the company’s regulatory compliance team, product quality and its vision to make India a global hub for healthcare manufacturing. He highlighted that the early completion of the Silvassa expansion enhances the firm’s ability to serve international markets and underscores its commitment to showcasing Indian industry potential through high‑quality, regulatory‑compliant products.
For further information, the company directed readers to its website at https://lordsmark.com/.